Market Value6,774,577,416
Total Holdings69
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TNGX / Tango Therapeutics, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
LENZ / LENZ Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
APYX / Apyx Medical Corporation
ARVN / Arvinas, Inc.
PTGX / Protagonist Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
KYTX / Kyverna Therapeutics, Inc.
NGNE / Neurogene Inc.
GKOS / Glaukos Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
SABS / SAB Biotherapeutics, Inc.
SGHT / Sight Sciences, Inc.
SWTX / SpringWorks Therapeutics, Inc.
DHR / Danaher Corporation
GH / Guardant Health, Inc.
SIENQ / Sientra, Inc.
CLDX / Celldex Therapeutics, Inc.
BRKR / Bruker Corporation
LRMR / Larimar Therapeutics, Inc.
RDNT / RadNet, Inc.
EXAS / Exact Sciences Corporation
AKRO / Akero Therapeutics, Inc.
VCEL / Vericel Corporation
VRDN / Viridian Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
TXG / 10x Genomics, Inc.
AVADEL PHARMACEUTICALS PLC / SPONSORED ADR (05337M104)
SWAV / Shockwave Medical, Inc.
TMO / Thermo Fisher Scientific Inc.
ISRG / Intuitive Surgical, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ROIV / Roivant Sciences Ltd.
TRML / Tourmaline Bio, Inc.
DYN / Dyne Therapeutics, Inc.
CUTRQ / Cutera, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
SYK / Stryker Corporation
AXSM / Axsome Therapeutics, Inc.
ALKS / Alkermes plc
STOK / Stoke Therapeutics, Inc.
IMTX / Immatics N.V.
XGN / Exagen Inc.
MIST / Milestone Pharmaceuticals Inc.
TARS / Tarsus Pharmaceuticals, Inc.
CRGX / CARGO Therapeutics, Inc.
SABS / SAB Biotherapeutics, Inc.
GHRS / GH Research PLC
OBIO / Orchestra BioMed Holdings, Inc.
CYTK / Cytokinetics, Incorporated
ETNB / 89bio, Inc.
PEN / Penumbra, Inc.
TSHA / Taysha Gene Therapies, Inc.
MRUS / Merus N.V.
IMUX / Immunic, Inc.
ESTA / Establishment Labs Holdings Inc.
XAIR / Beyond Air, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
SGMT / Sagimet Biosciences Inc.
PTCT / PTC Therapeutics, Inc.
INSM / Insmed Incorporated
ALUR / Allurion Technologies Inc.
CGON / CG Oncology, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
SLRN / Acelyrin, Inc.
SYRE / Spyre Therapeutics, Inc.
URGN / UroGen Pharma Ltd.
ACAD / ACADIA Pharmaceuticals Inc.
RGNX / REGENXBIO Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ARYD / ARYA Sciences Acquisition Corp IV
MASI / Masimo Corporation
NTRA / Natera, Inc.
ACET / Adicet Bio, Inc.
RNA / Avidity Biosciences, Inc.